Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUC029 Gel in Superficial Infantile Hemangioma
CTR20200156Phase 2Completed
- Sponsor
- Aucta Pharmaceuticals, Inc.
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timolol in Capillary Haemangioma, sponsored by Aucta Pharmaceuticals, Inc.. Started Feb 2020; status: completed.
02
Drugs
timolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on CTR20200156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200156.